Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations

被引:142
作者
Leveillard, T
Andera, L
Bissonnette, N
Schaeffer, L
Bracco, L
Egly, JM
Wasylyk, B
机构
[1] INST GENET & BIOL MOL & CELLULAIRE,F-67404 ILLKIRCH GRAFFENS,FRANCE
[2] RHONE POULENC RORER,CRVA,F-4403 VITRY,FRANCE
关键词
cell cycle control; DNA repair; transcription; tumour suppressor; xeroderma pigmentosum;
D O I
10.1002/j.1460-2075.1996.tb00506.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumour suppressor is mutated in the majority of human tumours. p53's proposed role as the guardian of the genome is reflected in its multiple effects on transcription, genome stability, cell growth and survival. We show that p53 interacts both physically and functionally with the TFIIH complex. There are multiple protein-protein contacts, involving two regions of p53 and three subunits of TFIIH, ERCC2 (XPD), ERCC3 (XPB) and p62, p53 and its C-terminus (amino acids 320-393) inhibit both of the TFIIH helicases and in vitro transcription in the absence of TFIIH. Transcription inhibition is overcome by TFIIH. The N-terminal region of p53 (1-320), lacking the C-terminus, ia inactive on its own, yet apparently affects the activity of the C-terminus in the native protein. Interestingly, mutant p53s that are frequently found in tumours are less efficient inhibitors of the helicases and transcription. We hypothesize that the interactions provide an immediate and direct link for p53 to the multiple functions of TFIIH in transcription, DNA repair and possibly the cell cycle.
引用
收藏
页码:1615 / 1624
页数:10
相关论文
共 99 条
[31]   INDUCTION OF APOPTOSIS IN HELA-CELLS BY TRANS-ACTIVATION-DEFICIENT P53 [J].
HAUPT, Y ;
ROWAN, S ;
SHAULIAN, E ;
VOUSDEN, KH ;
OREN, M .
GENES & DEVELOPMENT, 1995, 9 (17) :2170-2183
[32]  
HAVRE PA, 1995, CANCER RES, V55, P4420
[33]  
HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571
[34]   NUCLEOTIDE EXCISION REPAIR .2. FROM YEAST TO MAMMALS [J].
HOEIJMAKERS, JHJ .
TRENDS IN GENETICS, 1993, 9 (06) :211-217
[35]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[36]   2 DOMAINS OF P53 INTERACT WITH THE TATA-BINDING PROTEIN, AND THE ADENOVIRUS-13S E1A-PROTEIN DISRUPTS THE ASSOCIATION, RELIEVING P53-MEDIATED TRANSCRIPTIONAL REPRESSION [J].
HORIKOSHI, N ;
USHEVA, A ;
CHEN, JD ;
LEVINE, AJ ;
WEINMANN, R ;
SHENK, T .
MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) :227-234
[37]   SMALL PEPTIDES ACTIVATE THE LATENT SEQUENCE-SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
SPARKS, A ;
LANE, DP .
CELL, 1995, 83 (02) :237-245
[38]   REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
MEEK, DW ;
MIDGLEY, CA ;
LANE, DP .
CELL, 1992, 71 (05) :875-886
[39]   INCREASED UV-INDUCED SCES BUT NORMAL REPAIR OF DNA-DAMAGE IN P53-DEFICIENT MOUSE CELLS [J].
ISHIZAKI, K ;
EJIMA, Y ;
MATSUNAGA, T ;
HARA, R ;
SAKAMOTO, A ;
IKENAGA, M ;
IKAWA, Y ;
AIZAWA, S .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) :254-257
[40]   ACTIVATION OF P53 SEQUENCE-SPECIFIC DNA-BINDING BY SHORT SINGLE STRANDS OF DNA REQUIRES THE P53 C-TERMINUS [J].
JAYARAMAN, L ;
PRIVES, C .
CELL, 1995, 81 (07) :1021-1029